Quarterly report pursuant to Section 13 or 15(d)

12. SEGMENTS

v3.20.2
12. SEGMENTS
3 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
SEGMENTS

12. SEGMENTS

 

We operate our businesses principally through two reportable segments: Aethlon, which represents our therapeutic business activities, and Exosome Sciences, Inc., or ESI, which represents our diagnostic business activities. Our reportable segments have been determined based on the nature of the potential products being developed. We record discrete financial information for ESI and our chief operating decision maker reviews ESI’s operating results in order to make decisions about resources to be allocated to the ESI segment and to assess its performance.

 

Aethlon’s revenue is generated primarily from government contracts to date and ESI does not yet have any revenues. We have not included any allocation of corporate overhead to the ESI segment.

   

The following tables set forth certain information regarding our segments:

 

    Three Months Ended June 30,  
    2020     2019  
Revenues:            
Aethlon   $     $ 30,000  
ESI            
Total Revenues   $     $ 30,000  
                 
Operating Losses:                
Aethlon   $ (1,406,103 )   $ (1,561,885 )
ESI     (4,315 )     (4,303 )
Total Operating Loss   $ (1,410,418 )   $ (1,566,188 )
                 
Net Losses:                
Aethlon   $ (1,406,831 )   $ (2,062,981 )
ESI     (4,315 )     (4,303 )
Net Loss Before Non-Controlling Interests   $ (1,411,146 )   $ (2,067,284 )
                 
Cash:                
Aethlon   $ 15,721,419     $ 2,492,170  
ESI     197       184  
Total Cash   $ 15,721,616     $ 2,492,354  
                 
Total Assets:                
Aethlon   $ 16,427,057     $ 2,932,721  
ESI     197       184  
Total Assets   $ 16,427,254     $ 2,932,905  
                 
Capital Expenditures:                
Aethlon   $ 17,809     $ 886  
ESI            
Capital Expenditures   $ 17,809     $ 886  
                 
Depreciation and Amortization:                
Aethlon   $ 8,770     $ 2,868  
ESI            
Total Depreciation and Amortization   $ 8,770     $ 2,868  
                 
Interest Expense:                
Aethlon   $ (728 )   $ (54,085 )
ESI            
Total Interest Expense   $ (728 )   $ (54,085 )